Cardiovascular and Prothrombotic Risk in Patients With Oral Lichen Planus.
NCT07151014 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2026-01-12
Summary
The primary objective is to evaluate the cardiovascular profile and the risk of thrombotic events in patients affected by Oral Lichen Planus.
Conditions
- Oral Lichen Planus
Interventions
- OTHER
-
blood sample collection
blood sample collection in old patients in order to study the trombophilic risk
Sponsors & Collaborators
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-31
- Primary Completion
- 2026-09-15
- Completion
- 2027-02-15
More Related Trials
-
The Association Between Diabetes Mellitus, Oral Lichen Planus and Insulin-like Growth Factors 1 and 2 (IGF1 and IGF2)
NCT03257228 ·Status: COMPLETED
-
Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients
NCT01044043 ·Status: COMPLETED
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus Erythematosus
NCT04356014 ·Status: UNKNOWN
-
Assessment of Platelet Storage Lesion(PSL)in Platelet Concentrates
NCT05144074 ·Status: UNKNOWN
-
Methods Validation Assessment for Study of Inflammatory Skin Disease
NCT03796806 ·Status: COMPLETED
-
Identification of Oral Lesions Through an Autofluorescence System
NCT05942794 ·Status: RECRUITING ·Phase: NA
-
Phenotypic and Functional Profile of Peripheral Blood Lymphomonocytes in Seborrheic Dermatitis.
NCT07297446 ·Status: COMPLETED
-
Coagulation Activation in Patients With Pemphigus
NCT06285435 ·Status: NOT_YET_RECRUITING
-
Use of Platelet Rich Plasma from Cord Blood Vs Placebo in the Treatment of Vulvar Lichen Sclerosus
NCT06661382 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Psoriasis and the Risk of Cardiovascular Disease. A Prospective Study
NCT01382784 ·Status: UNKNOWN
-
Plexin D1 as a Potential Biomarker inPM/DM
NCT05637931 ·Status: UNKNOWN
-
Coagulopathy of Immunodermatologic Diseases
NCT06037187 ·Status: RECRUITING
-
Autoimmune Blistering Diseases Study
NCT02753777 ·Status: RECRUITING
-
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
NCT03509064 ·Status: RECRUITING
-
Investigation of Coronary and Pulmonary Circulatory Parameters in Systemic Sclerosis
NCT00843102 ·Status: COMPLETED
-
Platelet Gel in Systemic Sclerosis
NCT00463125 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Serum IL-21 Levels in Patients With Pemphigus Vulgaris
NCT03177213 ·Status: UNKNOWN
-
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
NCT06387654 ·Status: RECRUITING
-
Expression of miRNa-138 and Cyclin D1 in Oral Mucosa of Patients With Oral Lichen Planus
NCT02834520 ·Status: COMPLETED
-
Oral Manifestations of Systemic Sclerosis
NCT02371005 ·Status: TERMINATED ·Phase: NA
-
Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the CARNEY Complex (CNC)
NCT00668291 ·Status: COMPLETED
-
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3
-
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
NCT04892381 ·Status: UNKNOWN